Spencer David M.

Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC

Sold, on record
$1.9M
Dollars the filings state
Form 4 sales
12
Latest Sep 4, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Aug 15, 2016 2016

    Sold 1,000 shares at $20.00 ($20k)

    Spencer David M., Chief Scientific Officer

    Sold 0.6% of holdings ($3.5M position)175,082 shares left0.1x usual sizeFiling

  2. 2 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Sep 20, 2016 +36 days

    Sold 2,500 shares at $20.01 ($50k)

    Spencer David M., Chief Scientific Officer

    Sold 1.4% of holdings ($3.5M position)172,582 shares left0.5x usual sizeFiling

  3. 3 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusual
    Sep 23, 2016 +3 days

    Sold 16,500 shares at $19.88 ($328k)

    Spencer David M., Chief Scientific Officer

    Sold 9.6% of holdings ($3.4M position)156,082 shares left3.3x usual sizeFiling

  4. 4 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Dec 1, 2016 +69 days

    Sold 5,000 shares at $17.52 ($88k)

    Spencer David M., Chief Scientific Officer

    Sold 3.2% of holdings ($2.7M position)151,082 shares left1x usual sizeFiling

  5. 5 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Dec 5, 2016 +4 days

    Sold 5,000 shares at $20.00 ($100k)

    Spencer David M., Chief Scientific Officer

    Sold 3.3% of holdings ($3M position)146,082 shares left1x usual sizeFiling

  6. 6 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Jul 10, 2017 +217 days

    Sold 10,000 shares at $11.54 ($115k)

    Spencer David M., Chief Scientific Officer

    Sold 6.7% of holdings ($1.7M position)138,965 shares left2x usual sizeFiling

  7. 7 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusual
    Jul 18, 2018 +373 days

    Sold 40,000 shares at $7.63 ($305k)

    Spencer David M., Chief Technology Officer

    Sold 28.6% of holdings ($1.1M position)99,939 shares left8x usual sizeFiling

  8. 8 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Sep 4, 2018 +48 days

    Sold 10,000 shares at $7.04 ($70k)

    Spencer David M., Chief Technology Officer

    Sold 10% of holdings ($704k position)89,939 shares left1.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Spencer David M.
Source
Sep 4, 2018Sep 5, 2018BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale10,000$70k10.0%Plan not statedSEC
Jul 18, 2018Jul 20, 2018BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale40,000$305k28.6%UnusualSEC
Jul 10, 2017Jul 12, 2017BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale10,000$115k6.7%Plan not statedSEC
Dec 5, 2016Dec 5, 2016BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale5,000$100k3.3%Plan not statedSEC
Dec 1, 2016Dec 5, 2016BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale5,000$88k3.2%Plan not statedSEC
Sep 23, 2016Sep 23, 2016BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale16,500$328k9.6%UnusualSEC
Sep 20, 2016Sep 20, 2016BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale2,500$50k1.4%Plan not statedSEC
Aug 15, 2016Aug 17, 2016BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale1,000$20k0.6%Plan not statedSEC
Jul 27, 2016Jul 29, 2016BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale10,000$150k5.4%Plan not statedSEC
Dec 1, 2015Dec 3, 2015BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale5,000$115k2.7%Plan not statedSEC
Sep 11, 2015Sep 15, 2015BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale5,000$95k2.7%Plan not statedSEC
Jun 16, 2015Jun 18, 2015BELLICUM PHARMACEUTICALS, INCChief Scientific OfficerForm 4 sale20,000$459k10.9%Plan not statedSEC